The NFL’s Joint Pain Management Committee awarded a $1 million research grant to two medical teams who will study how cannabinoids impact pain management and “neuroprotection from concussion” for players.

The committee of NFL and NFL Players Association leaders selected two out of 106 prospective medical teams to quarterback the seven-figure study. The University of California San Diego and University of Regina in Canada will host the league’s weed research for the next three years. And researchers will have a high burden of proof, according to NFL chief medical officer Dr. Allen Sills.

”Anytime we want to introduce a new therapy, we have to understand how that decision might impact their well-being and their performance,” Dr. Sills told the…

To continue reading, visit the original article at